Bottom line
Is BIVIX a good fund? The bottom line
BIVIX is a share class of Invenomic Fund, a managed large blend mutual fund from Fidelity.
Its expense ratio is 3.05% — about $305 a year on every $10,000 invested, more expensive than 99% of large blend funds we track.
It returned +4.6% over one year, +21.9% a year over five years (as of Dec 31, 2025, per its prospectus).
With $855 million in net assets and 219 holdings, its largest position is First American Funds Inc (8.8%) and the top 10 make up 35.2% of the portfolio.
What stands out
- 5-year return beat 100% of category peers
- Broadly diversified (219 holdings)
- No front-end sales load
What to watch
- Expensive for its category (3.05%)
- High turnover (197% a year) can mean more taxable distributions
Updated Nov 19, 2026
What BIVIX invests in
The investment objective of the Invenomic Fund (the ?Fund?) is to seek long term capital appreciation.
T he Fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Adviser seeks to be fully invested in the long portfolio (greater than 80%), while allowing the size of the short portfolio to fluctuate based on the market opportunity. The long positions are identified by the Fund?s adviser, Invenomic Capital Management, LP (the ?Adviser?) as securities that are both undervalued and timely, where the Adviser believes that the return potential compensates for the risk involved. The short positions are identified as securities that the Adviser believes are overvalued and that the price of the security will fall, delivering both a positive return for the Fund while simultaneously reducing the overall risk of the portfolio. The Adviser evaluates long and short positions on multiple…
From the fund's prospectus (filed Mar 2, 2026).
BIVIX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| BIVIX | +4.6% | +21.9% | — |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What BIVIX costs
On a $10,000 investment, BIVIX's 3.05% expense ratio costs about $305 a year. The prospectus estimates $3,382 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
BIVIX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | First American Funds Inc | 8.82% |
| 2 | Workday Inc | 3.38% |
| 3 | Salesforce Inc | 3.11% |
| 4 | Universal Health Services Inc | 3.09% |
| 5 | Global Payments Inc | 3.07% |
| 6 | Intuit Inc | 2.93% |
| 7 | Fidelity National Information Services Inc | 2.87% |
| 8 | Charter Communications Inc | 2.81% |
| 9 | Fiserv Inc | 2.56% |
| 10 | Dentsply Sirona Inc | 2.54% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 35.2% of the fund. See all top 25 holdings and asset mix →